High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  López Sánchez, Marta ^a   Muñoz Esquerre, Mariana ^a,b   Huertas, Daniel ^a   Gonzalez Costello, José ^b   Ribas, Jesús ^a,b   Manresa, Federico ^a,b   Dorca, Jordi ^a,b   Santos, Salud ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTERIAL GAS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HEART RIGHT VENTRICLE OVERLOAD; HUMAN; HYPERINFLATION; HYPOXEMIA; INFLAMMATION; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEUKOCYTE; LINEAR REGRESSION ANALYSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATHOGENESIS; PREVALENCE; TOBACCO; WALKING; AGED; BLOOD; BLOOD GAS ANALYSIS; DIAGNOSTIC IMAGING; EXERCISE TEST; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

NICOTIANA TABACUM;

AGED; BIOMARKERS; BLOOD GAS ANALYSIS; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENTS; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84879509653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068034     Document Type: Article

References (40)

1. Barnes PJ, Celli BR, (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33: 1165-1185. doi:10.1183/09031936.00128008. PubMed: 19407051.
2. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W, Trevisan M, (2000) Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118: 656-664. doi:10.1378/chest.118.3.656. PubMed: 10988186.
3. Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, et al. (2003) Lung function and incident coronary heart disease: the Atherosclerosis Risk In Communities Study. Am J Epidemiol 158: 1171-1181. doi:10.1093/aje/kwg276. PubMed: 14652302.
4. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner, REEet al (2005) The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142: 233-239. doi:10.7326/0003-4819-142-4-200502150-00005. PubMed: 15710956.
5. Rutten FH, Moons KG, Cramer MJ, Grobbee DE, Zuithoff NP, et al. (2005) Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 331: 1379. doi:10.1136/bmj.38664.661181.55. PubMed: 16321994.
6. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW, (2006) Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail 8: 706-711. doi:10.1016/j.ejheart.2006.01.010. PubMed: 16531114.
7. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, et al. (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26: 1887-1894. doi:10.1093/eurheartj/ehi291. PubMed: 15860516.
8. Jörgensen K, Müller MF, Nel J, Upton RN, Houltz E, et al. (2007) Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: An MRI study. Chest 131: 1050-1057. doi:10.1378/chest.06-2245. PubMed: 17426209.
9. Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, et al. (2010) Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: Role of hyperinflation. Chest 138: 32-38. doi:10.1378/chest.10312. PubMed: 20190002.
10. Jörgensen K, Houltz E, Westfelt U, Nilsson F, Scherstén H, et al. (2003) Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema. Chest 124: 1863-1870. doi:10.1378/chest.124.5.1863. PubMed: 14605061.
11. Criner GJ, Scharf SM, Falk JA, Gaughan JP, Sternberg AL, et al. (2007) Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema. Am J Respir Crit Care Med 176: 253-260. doi:10.1164/rccm.200608-1114OC. PubMed: 17496227.
12. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, et al. (2010) Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 362: 217-227. doi:10.1056/NEJMoa0808836. PubMed: 20089972.
13. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555. doi:10.1164/rccm.200703-456SO. PubMed: 17507545.
14. Miller MR, Hankinson J, Brusasco V F, Casaburi R et al (2005) Series ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 26: 319-338. doi:10.1183/09031936.05.00034805. PubMed: 16055882.
15. Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, et al. (1996) Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 9: 736-760. doi:10.1016/S0894-7317(96)90076-0. PubMed: 8887883.
16. ATS (2002) statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111-117. doi:10.1164/ajrccm.166.1.at1102. PubMed: 12091180.
17. Abhayaratna WP, Marwick TH, Smith WT, Becker NG, (2006) Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart 92: 1259-1264. doi:10.1136/hrt.2005.080150. PubMed: 16488928.
18. Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, et al. (2003) Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 24: 320-328. doi:10.1016/S0195-668X(02)00428-1. PubMed: 12581679.
19. Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, et al. (2000) Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med 162: 670-675. doi:10.1164/ajrccm.162.2.9908056. PubMed: 10934104.
20. Funk GC, Lang I, Schenk P, Valipour A, Hartl S, et al. (2008) Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest 133: 1354-1359. doi:10.1378/chest.07-2685. PubMed: 18339780.
21. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, et al. (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171: 972-977. doi:10.1164/rccm.200407-855OC. PubMed: 15665324.
22. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, et al. (2008) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 177: 743-751. doi:10.1164/rccm.200707-1011OC. PubMed: 18048807.
23. Rabinovich RA, Vilaró J, Roca J, (2004) [Evaluation exercise tolerance in COPD patients: The 6-minute walking test]. Arch Bronconeumol 40(2):: 80-85. doi:10.1157/13056713. PubMed: 14746731.
24. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR, (2004) The 6-min walk distance: Change over time and value as a predictor of survival in severe COPD. Eur Respir J 23: 28-33. doi:10.1183/09031936.03.00034603. PubMed: 14738227.
25. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, et al. (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350: 1005-1012. doi:10.1056/NEJMoa021322. PubMed: 14999112.
26. Malerba M, Ragnoli B, Salameh M, Sennino G, Sorlini ML, et al. (2011) Sub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease. J Biol Regul Homeost Agents 25(3):: 443-451. PubMed: 22023769.
27. Cuttica MJ, Shah SJ, Rosenberg SR, Orr R, Beussink L, et al. (2011) Right heart structural changes are independently associated with exercise capacity in non-severe COPD. PLOS ONE 6(12):: 1-8. PubMed: 22220201.
28. Sims MW, Margolis DJ, Localio AR, Panettieri RA, Kawut SM, et al. (2009) Impact of pulmonary artery pressure on exercise function in severe COPD. Chest 136: 412-419. doi:10.1378/chest.08-2739. PubMed: 19318664.
29. Abroug F, Ouanes-Besbes L, Nciri N, Sellami N, Addad F, et al. (2006) Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: Diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med;174: 990-996. doi:10.1164/rccm.200603-380OC. PubMed: 16840745.
30. Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Díaz H, et al. (2008) Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 32: 1275-1282. doi:10.1183/09031936.00151707. PubMed: 18550609.
31. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, et al. (2002) Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 166: 314-322. doi:10.1164/rccm.2107027. PubMed: 12153963.
32. Kasner M, Westermann D, Steendijk P, Dröse S, Poller W, et al. (2012) Left ventricular dysfunction induced by nonsevere idiopathic pulmonary arterial hypertension: A pressure-volume relationship studyLV. Am J Respir Crit Care Med 186: 181-189. doi:10.1164/rccm.201110-1860OC. PubMed: 22561959.
33. Vonk Noordegraaf A, Marcus JT, Roseboom B, Postmus PE, Faes TJ, et al. (1997) The effect of right ventricular hypertrophy on left ventricular ejection fraction in pulmonary emphysema. Chest 112: 640-645. doi:10.1378/chest.112.3.640. PubMed: 9315795.
34. Yilmaz R, Gencer M, Ceylan E, (2005) Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance. J Am Soc Echocardiogr 18: 873-881. doi:10.1016/j.echo.2005.01.016. PubMed: 16084341.
35. Santos S, Peinado VI, Ramirez J, Morales-Blanhir J, Bastos R, et al. (2003) Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1250-1256. doi:10.1164/rccm.200210-1233OC. PubMed: 12615615.
36. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, et al. (1991) Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 324: 1539-1547. doi:10.1056/NEJM199105303242203. PubMed: 2027358.
37. Müller NL, Staples CA, Miller RR, Abboud RT, (1988) "Density mask". An objective method to quantitate emphysema using computed tomography. Chest 94: 782-787. doi:10.1378/chest.94.4.782. PubMed: 3168574.
38. Larsen KO, Sjaastad I, Svindland A, Krobert KA, Skjønsberg OH, et al. (2006) Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice. Am J Physiol Heart Circ Physiol 291: H507-H516. doi:10.1152/ajpheart.00862.2005. PubMed: 16582020.
39. Peinado VI, Barberá JA, Abate P, Ramírez J, Roca J, et al. (1999) Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159: 1605-1611. doi:10.1164/ajrccm.159.5.9807059. PubMed: 10228134.
40. Sin DD, Man SF, (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107: 1514-1519. doi:10.1161/01.CIR.0000056767.69054.B3. PubMed: 12654609.